P
Peptides 4 Research
Request Full Data Access to the Medutest database of peptide tests.
Products examined
| Product | Rating | Samples | Avg | Min | Max | Latest |
|---|---|---|---|---|---|---|
| GHK-Cu | C | 4 | 5.0 | 4.8 | 5.2 | 6 May 2025 |
| Ipamorelin | D | 4 | 4.4 | 3.2 | 5.0 | 7 May 2025 |
| BPC-157 | D | 4 | 4.3 | 3.7 | 4.8 | 7 May 2025 |
| CJC-1295 | E | 4 | 3.7 | 3.1 | 4.2 | 7 May 2025 |
| Tesamorelin | E | 4 | 4.0 | 3.4 | 4.6 | 7 May 2025 |
| AA Water | C | 2 | 5.2 | 4.0 | 6.5 | 24 May 2026 |
| ACE-031 | C | 2 | 4.0 | 2.0 | 2.4 | 17 May 2026 |
| Adipotide | C | 2 | 4.0 | 3.4 | 3.7 | 17 May 2026 |
| Alprostadil | X | 1 | 4.0 | 2.3 | 2.3 | 21 May 2025 |
| BAC Water | C | 2 | 5.5 | 5.0 | 5.9 | 24 May 2026 |
| Blend 375 (Tren E 125mg+Mast E 125mg+Test E 125mg) | C | 2 | 5.0 | 3.6 | 6.3 | 19 Jan 2026 |
| BMK glycidic acid (free acid) CAS 25547-51-7 | C | 2 | 4.0 | 2.8 | 3.4 | 19 Jan 2026 |
| Cartalax | C | 2 | 5.1 | 4.6 | 5.6 | 24 May 2026 |
| CJC-1295 w/o DAC 10mg + IPA 10mg Blend | X | 1 | 4.0 | 3.8 | 3.8 | 13 Jun 2025 |
| DHB (1-Test Cyp) Oral | X | 1 | 4.0 | 2.9 | 2.9 | 13 Feb 2025 |
| Dianabol Oil | X | 1 | 5.0 | 5.0 | 5.0 | 9 Jun 2025 |
| DNP | C | 2 | 4.2 | 3.9 | 4.4 | 17 May 2026 |
| Epithalon | X | 1 | 5.0 | 5.0 | 5.0 | 21 May 2025 |
| EPO | X | 1 | 6.3 | 6.3 | 6.3 | 3 Jul 2025 |
| GHRP-2 Acetate | X | 1 | 6.6 | 6.6 | 6.6 | 6 May 2025 |
| Glutathione | X | 1 | 4.0 | 3.1 | 3.1 | 9 Jun 2025 |
| HMG | X | 1 | 4.3 | 4.3 | 4.3 | 13 Feb 2025 |
| Humanin | C | 2 | 5.2 | 4.6 | 5.7 | 21 May 2026 |
| Hyaluronic acid | C | 2 | 4.8 | 4.1 | 5.4 | 23 May 2026 |
| IGF-1 LR3 | C | 2 | 5.2 | 4.2 | 6.2 | 19 Jan 2026 |
| Immunological Enhancement (Glutathione 200mg+Ascorbic Acid 200mg+Zinc Sulfate 2.5mg) | X | 1 | 4.0 | 3.7 | 3.7 | 25 Apr 2025 |
| Isotretinoin | X | 1 | 4.4 | 4.4 | 4.4 | 13 Jun 2025 |
| KissPeptin-10 | C | 2 | 4.2 | 2.9 | 5.4 | 19 Jan 2026 |
| KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | C | 2 | 4.5 | 1.9 | 7.0 | 25 May 2026 |
| KPV Oral | C | 2 | 5.1 | 4.5 | 5.7 | 24 May 2026 |
| Orforglipron | X | 1 | 6.8 | 6.8 | 6.8 | 21 May 2025 |
| Oxymetholone (Anadrol) Raw | C | 2 | 4.1 | 1.4 | 6.8 | 25 May 2026 |
| P-2-P (phenyl-2-propanone / BMK) CAS 103-79-7 | C | 2 | 5.8 | 5.5 | 6.2 | 23 May 2026 |
| P21 | X | 1 | 4.0 | 3.1 | 3.1 | 9 Jun 2025 |
| PMK ethyl glycidate (3,4-MDP-2-P ethyl glycidate) CAS 28578-16-7 | X | 1 | 4.0 | 3.4 | 3.4 | 2 Apr 2025 |
| Prednisone | X | 1 | 7.0 | 7.0 | 7.0 | 3 Jul 2025 |
| PTD-DBM | C | 2 | 4.6 | 2.2 | 7.0 | 25 May 2026 |
| Relaxation PM (GABA 100mg+Melatonin 1mg+Arginine 100mg+Glutamine 25mg) | C | 2 | 4.8 | 3.8 | 5.7 | 19 Jan 2026 |
| Salbutamol | C | 2 | 4.9 | 4.8 | 5.0 | 24 May 2026 |
| Selank 10mg + Semax 10mg Blend | C | 2 | 4.0 | 2.5 | 5.2 | 19 Jan 2026 |
| Semaglutide Raw | C | 2 | 5.0 | 3.9 | 6.2 | 21 May 2026 |
| SNAP-8 | C | 2 | 4.1 | 2.0 | 6.2 | 19 Jan 2026 |
| Super Human Blend (Arginine+Ornithine+Citrulline+Lysine+Glutamine+Proline+Taurine+Carnitine+NAC) | X | 1 | 4.0 | 2.3 | 2.3 | 27 Feb 2025 |
| Tesamorelin 11mg + Ipamorelin 6mg Blend | X | 1 | 4.0 | 3.0 | 3.0 | 3 Jul 2025 |
| Testosterone Propionate Raw | X | 1 | 5.5 | 5.5 | 5.5 | 2 Jul 2025 |
| Tirzepatide Oral | X | 1 | 4.0 | 2.7 | 2.7 | 13 Feb 2025 |
The certificates
| Date | Product | Score | Declared | Measured | Deviation | Purity | Laboratory |
|---|---|---|---|---|---|---|---|
| 25 May 2026 | Testosterone Propionate Raw | 4.4 | 500g | 428.6g | -14.3% | 95.68% | Lab A |
| 24 May 2026 | DNP | 4.0 | 10mg | 8.9mg | -11.5% | 97.72% | Lab C |
| 24 May 2026 | Relaxation PM (GABA 100mg+Melatonin 1mg+Arginine 100mg+Glutamine 25mg) | 4.7 | 200mg/ml | 202.6mg/ml | +1.3% | 96.51% | Lab G |
| 24 May 2026 | Adipotide | 5.7 | 2mg | 2.5mg | +23.9% | 96.26% | Lab F |
| 24 May 2026 | AA Water | 6.2 | 50mg | 52.7mg | +5.5% | 99.10% | Lab E |
| 24 May 2026 | Isotretinoin | 4.0 | 100mg | 108.5mg | +8.5% | 99.87% | Lab G |
| 24 May 2026 | BMK glycidic acid (free acid) CAS 25547-51-7 | 4.5 | 500g | 442.6g | -11.5% | 95.26% | Lab D |
| 24 May 2026 | KPV Oral | 5.7 | 20mg | 18.3mg | -8.7% | 96.86% | Lab C |
| 24 May 2026 | Oxymetholone (Anadrol) Raw | 4.7 | 10g | 11.1g | +11.1% | 97.73% | Lab G |
| 24 May 2026 | Semaglutide Raw | 6.7 | 1g | 0.9g | -5.3% | 95.12% | Lab A |
| 24 May 2026 | KPV Oral | 4.5 | 25mg | 26.9mg | +7.6% | 99.73% | Lab D |
| 23 May 2026 | Blend 375 (Tren E 125mg+Mast E 125mg+Test E 125mg) | 4.3 | 200mg/ml | 241.3mg/ml | +20.7% | 96.58% | Lab B |
| 23 May 2026 | Salbutamol | 4.9 | 20mg | 19.4mg | -3.2% | 96.86% | Lab F |
| 21 May 2026 | HMG | 6.0 | 30mg | 29.1mg | -2.9% | 98.84% | Lab A |
| 21 May 2026 | P-2-P (phenyl-2-propanone / BMK) CAS 103-79-7 | 6.7 | 10g | 9.8g | -1.7% | 97.99% | Lab C |
| 21 May 2026 | PTD-DBM | 5.1 | 50mg | 50.7mg | +1.3% | 98.41% | Lab D |
| 21 May 2026 | Tesamorelin 11mg + Ipamorelin 6mg Blend | 5.0 | 15mg | 15.7mg | +4.8% | 98.59% | Lab A |
| 20 May 2026 | ACE-031 | 4.0 | 2mg | 2.3mg | +17.2% | 98.70% | Lab E |
| 20 May 2026 | BAC Water | 7.8 | 30mg | 32.1mg | +6.9% | 98.18% | Lab D |
| 19 May 2026 | Epithalon | 4.1 | 2mg | 2.0mg | +1.0% | 96.44% | Lab G |
| 19 May 2026 | Salbutamol | 5.2 | 25mg | 29.1mg | +16.5% | 97.69% | Lab B |
| 17 May 2026 | AA Water | 4.4 | 50mg | 53.7mg | +7.5% | 95.65% | Lab A |
| 17 May 2026 | Humanin | 7.5 | 5mg | 5.5mg | +10.9% | 98.83% | Lab D |
| 17 May 2026 | P21 | 5.4 | 5mg | 5.3mg | +5.5% | 95.94% | Lab A |
| 29 Jan 2026 | Orforglipron | 7.6 | 50mg | 57.2mg | +14.4% | 98.28% | Lab D |
| 29 Jan 2026 | Selank 10mg + Semax 10mg Blend | 4.6 | 15mg | 13.5mg | -9.9% | 97.89% | Lab B |
| 29 Jan 2026 | SNAP-8 | 6.1 | 50mg | 50.1mg | +0.1% | 97.09% | Lab A |
| 26 Jan 2026 | DHB (1-Test Cyp) Oral | 4.0 | 100mg | 96.5mg | -3.5% | 99.77% | Lab A |
| 26 Jan 2026 | KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | 4.0 | 50mg | 55.8mg | +11.6% | 97.53% | Lab D |
| 26 Jan 2026 | PMK ethyl glycidate (3,4-MDP-2-P ethyl glycidate) CAS 28578-16-7 | 4.3 | 10g | 10.7g | +7.0% | 96.07% | Lab G |
| 26 Jan 2026 | Super Human Blend (Arginine+Ornithine+Citrulline+Lysine+Glutamine+Proline+Taurine+Carnitine+NAC) | 6.0 | 300mg/ml | 314.0mg/ml | +4.7% | 97.81% | Lab E |
| 9 Jan 2026 | DNP | 4.3 | 25mg | 28.3mg | +13.1% | 95.71% | Lab B |
| 9 Jan 2026 | Hyaluronic acid | 4.6 | 5mg | 4.4mg | -12.2% | 95.81% | Lab B |
| 9 Jan 2026 | KissPeptin-10 | 4.4 | 30mg | 28.6mg | -4.7% | 98.19% | Lab F |
| 7 Jan 2026 | IGF-1 LR3 | 5.5 | 2mg | 2.0mg | +0.6% | 97.79% | Lab A |
| 6 Jan 2026 | Selank 10mg + Semax 10mg Blend | 5.0 | 5mg | 6.0mg | +20.6% | 98.70% | Lab B |
| 29 Dec 2025 | BMK glycidic acid (free acid) CAS 25547-51-7 | 4.0 | 100g | 108.2g | +8.2% | 98.62% | Lab F |
| 29 Dec 2025 | KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | 4.5 | 50mg | 50.7mg | +1.5% | 98.29% | Lab D |
| 29 Dec 2025 | SNAP-8 | 4.0 | 2mg | 2.4mg | +22.0% | 96.34% | Lab C |
| 12 Dec 2025 | Cartalax | 5.1 | 30mg | 30.6mg | +2.1% | 97.94% | Lab G |
| 12 Dec 2025 | Oxymetholone (Anadrol) Raw | 4.0 | 500g | 439.2g | -12.2% | 97.98% | Lab B |
| 12 Dec 2025 | Semaglutide Raw | 4.0 | 5g | 5.2g | +3.7% | 98.47% | Lab E |
| 5 Dec 2025 | CJC-1295 w/o DAC 10mg + IPA 10mg Blend | 4.1 | 15mg | 15.3mg | +1.7% | 97.55% | Lab D |
| 5 Dec 2025 | PTD-DBM | 5.2 | 10mg | 8.8mg | -11.8% | 95.34% | Lab E |
| 23 Nov 2025 | Dianabol Oil | 6.0 | 100mg/ml | 85.8mg/ml | -14.2% | 95.55% | Lab D |
| 17 Nov 2025 | GHRP-2 Acetate | 7.1 | 20mg | 24.5mg | +22.5% | 96.65% | Lab F |
| 14 Nov 2025 | BAC Water | 4.0 | 10mg | 8.8mg | -11.9% | 96.24% | Lab A |
| 14 Nov 2025 | Blend 375 (Tren E 125mg+Mast E 125mg+Test E 125mg) | 4.0 | 100mg/ml | 119.0mg/ml | +19.0% | 96.28% | Lab E |
| 14 Nov 2025 | Cartalax | 5.7 | 50mg | 57.5mg | +15.0% | 95.29% | Lab E |
| 14 Nov 2025 | Humanin | 6.3 | 5mg | 4.3mg | -13.7% | 96.42% | Lab G |
| 5 Nov 2025 | P-2-P (phenyl-2-propanone / BMK) CAS 103-79-7 | 6.4 | 5g | 4.4g | -12.2% | 99.46% | Lab G |
| 4 Nov 2025 | Adipotide | 5.6 | 15mg | 16.4mg | +9.1% | 95.54% | Lab F |
| 4 Nov 2025 | Immunological Enhancement (Glutathione 200mg+Ascorbic Acid 200mg+Zinc Sulfate 2.5mg) | 4.8 | 300mg/ml | 374.0mg/ml | +24.7% | 97.98% | Lab G |
| 17 Oct 2025 | Alprostadil | 6.5 | 15mg | 18.1mg | +20.7% | 98.74% | Lab E |
| 17 Oct 2025 | EPO | 5.9 | 5mg | 4.4mg | -11.0% | 95.76% | Lab C |
| 17 Oct 2025 | Hyaluronic acid | 5.8 | 50mg | 44.1mg | -11.9% | 99.46% | Lab A |
| 17 Oct 2025 | Prednisone | 6.9 | 20mg | 24.1mg | +20.7% | 99.47% | Lab C |
| 17 Oct 2025 | Tirzepatide Oral | 6.1 | 25mg | 29.7mg | +18.9% | 98.32% | Lab G |
| 9 Oct 2025 | Relaxation PM (GABA 100mg+Melatonin 1mg+Arginine 100mg+Glutamine 25mg) | 4.0 | 250mg/ml | 242.3mg/ml | -3.1% | 99.42% | Lab A |
| 3 Oct 2025 | ACE-031 | 5.1 | 50mg | 55.6mg | +11.2% | 99.32% | Lab G |
| 3 Oct 2025 | Glutathione | 4.7 | 30mg | 35.0mg | +16.6% | 95.66% | Lab C |
| 3 Oct 2025 | IGF-1 LR3 | 4.1 | 10mg | 10.3mg | +3.1% | 95.23% | Lab E |
| 3 Oct 2025 | KissPeptin-10 | 4.0 | 5mg | 5.6mg | +12.6% | 97.31% | Lab C |
| 21 May 2025 | Tesamorelin | 3.4 | 5mg | 4.11mg | -17.8% | White Label / Silver Crimp / Black caps | |
| 21 May 2025 | Tesamorelin | 4.5 | 5mg | 4.34mg | -13.2% | White Label / Silver Crimp / Black caps | |
| 20 May 2025 | CJC-1295 | No DAC | 3.8 | 5mg | 3.3mg | -34.0% | White Label / Silver Crimp / Black caps |
| 20 May 2025 | Ipamorelin | 4.7 | 5mg | 4.37mg | -12.6% | White Label / Silver Crimp / Black caps | |
| 20 May 2025 | GHK-Cu | 5.0 | 100mg | 82.91mg | -17.1% | White Label / Silver Crimp / Black caps | |
| 20 May 2025 | Ipamorelin | 3.2 | 5mg | 4.07mg | -18.6% | White Label / Silver Crimp / Black caps | |
| 20 May 2025 | CJC-1295 | No DAC | 3.1 | 5mg | 2.69mg | -46.2% | White Label / Silver Crimp / Black caps |